about
Pharmacy and pharmacology of biosimilars.Rituximab and biosimilars - equivalence and reciprocity.Bioanalytical strategy used in development of pharmacokinetic (PK) methods that support biosimilar programs.Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production.Emerging technologies in the delivery of erythropoietin for therapeutics.Biosimilar recombinant follicle stimulating hormones in infertility treatment.Biosimilar regulation in the EU.Biosimilar therapeutics-what do we need to consider?
P2860
Q30370042-4D942130-1503-4AE8-B6E9-A05498A33FE1Q33596879-0A735F42-36F3-40E4-A711-313016416F21Q36215497-36896E60-7941-4ACC-87E6-BB776FCA1E6FQ36603218-4BFB8B86-BD9B-4DF4-9C6D-618D0D890A53Q37646523-9BE01DDE-815F-4529-BB99-5625A663063DQ38217005-982B596B-A6AE-472F-8736-43B09062ED8FQ38570723-B9252086-D469-41A8-89E8-C96C05F1C268Q41841849-01E66496-4A4E-44FE-B950-98D17630B490
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
European regulatory guidelines for biosimilars.
@ast
European regulatory guidelines for biosimilars.
@en
type
label
European regulatory guidelines for biosimilars.
@ast
European regulatory guidelines for biosimilars.
@en
prefLabel
European regulatory guidelines for biosimilars.
@ast
European regulatory guidelines for biosimilars.
@en
P356
P1476
European regulatory guidelines for biosimilars.
@en
P2093
Andrzej Wiecek
Ashraf Mikhail
P304
P356
10.1093/NDT/GFL477
P407
P478
21 Suppl 5
P577
2006-10-01T00:00:00Z